ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977

Gallo To Give Scripps Symposium’s Schwartz Lecture

August 9, 1985

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

Foti Receives Del Duca Award; Wake Forest To Hire 60 Faculty.

February 11, 2000

Groups Urge Passage of Health Care Reform Legislation

January 29, 2010

House Disallows NCI Recision

March 14, 1975